Clinical Trial Update: Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing neoadjuvant temozolomide and bevacizumab before temozolomide plus radiation and bevacizumab in patients with unresectable glioblastoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Grupo Español de Investigación en Neurooncología | Conditions: Glioblastomas | Phase 2 | Status: COMPLETED